Shineco

Shineco EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Shineco (SISI) as of Nov 5, 2026 is -20.27 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -13.80 % — a change of 46.93% (lower).

EBIT/Assets

-20.27 %

YoY

46.93%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Shineco is 2024 -20.27 % . Operating Income to Assets Ratio (EBIT/Assets) of Shineco was 2023 -13.80 % . It decreases by 46.93% lower compared to the previous year.

The Shineco EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2017
10.90 USD
Jan 1, 2018
11.16 USD
Jan 1, 2019
0.38 USD
Jan 1, 2020
-4.41 USD
Jan 1, 2021
-34.92 USD
Jan 1, 2022
-9.71 USD
Jan 1, 2023
-13.80 USD
Jan 1, 2024
-20.27 USD
The Shineco EBIT/Assets history
YEAREBIT/AssetsYoY
-20.27 %+46.93%
-13.80 %+42.06%
-9.71 %-72.19%
-34.92 %+691.45%
-4.41 %-1,271.42%
0.38 %-96.62%
11.16 %+2.32%
10.90 %-15.26%
12.87 %+3.17%
12.47 %-25.91%
16.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shineco Stock analysis

What does Shineco do? Shineco, Inc. generates revenue through three operational segments. The Luobuma Products segment sells specialized fabrics, textiles, and by-products made from Apocynum Venetum, an indigenous Chinese plant, alongside raw material processing services. The Chinese Medicinal Herbal Products segment distributes traditional Chinese medicinal herbs and pharmaceutical products. The Other Agricultural Products segment focuses on green and organic agricultural produce, including yew tree cultivation and growth. These segments target health-conscious consumers and pharmaceutical distributors seeking plant-based solutions. The company's vertically and horizontally integrated production and distribution channels enable efficient delivery of its products. Subsidiaries and variable interest entities manage manufacturing, processing, and sales across all segments. The firm's products are sold to consumers and businesses within China's health and wellness market, emphasizing natural and organic offerings. Shineco's business model relies on the integration of its subsidiaries and variable interest entities to handle end-to-end operations. This structure supports the production and distribution of plant-based goods without external partnerships. The company's focus on Apocynum Venetum, traditional Chinese medicine, and organic agriculture defines its market positioning and revenue streams. Shineco is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shineco stock

Operating Income to Assets Ratio (EBIT/Assets) of Shineco is -20.27 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of Shineco changed from -13.80 % to -20.27 %, representing a 46.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Shineco since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Shineco with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Shineco

All Key Metrics — Shineco